Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis-Reference-Cited by-同舟云学术

Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Published:2016-07-12 Issue:1 Volume:66 Page:137-144
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Jendrek Sebastian Torben,Gotthardt Daniel,Nitzsche Thomas,Widmann Laila,Korf Tobias,Michaels Maike Anna,Weiss Karl-Heinz,Liaskou Evaggelia,Vesterhus Mette,Karlsen Tom Hemming,Mindorf Swantje,Schemmer Peter,Bär Florian,Teegen Bianca,Schröder Torsten,Ehlers Marc,Hammers Christoph Matthias,Komorowski Lars,Lehnert Hendrik,Fellermann Klaus,Derer Stefanie,Hov Johannes Roksund,Sina Christian

Publisher

BMJ

Subject

Gastroenterology

Reference35 articles.

1. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis;Bergquist;J Hepatol,2002

2. Primary sclerosing cholangitis as a pre-malignant biliary tract disease: Surveillance and Management;Rizvi;Clin Gastroenterol Hepatol,2015

3. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis;Broomé;Gut,1996

4. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer;Broomé;Semin Liver Dis,2006

5. Primary sclerosing cholangitis and malignancy;Boberg;Best Pract Res Clin Gastroenterol,2011

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial glycoprotein 2 (GP2) in gallstones, bile fluid and peribiliary glands of patients with primary sclerosing cholangitis;Clinica Chimica Acta;2024-08

2. Distinct metabolomic and lipidomic profiles in serum samples of patients with primary sclerosing cholangitis;Frontiers in Medicine;2024-06-04

3. Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts;Gastroenterology;2024-06

4. Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma;Digestive and Liver Disease;2024-06

5. Integrated combinatorial functional genomics and spatial transcriptomics of tumors decodes genotype to phenotype relationships;2024-05-17